Skip to main content
Top
Gepubliceerd in:

12-12-2017

Quality of life after hip, vertebral, and distal forearm fragility fractures measured using the EQ-5D-3L, EQ-VAS, and time-trade-off: results from the ICUROS

Auteurs: Axel Svedbom, Fredrik Borgström, Emma Hernlund, Oskar Ström, Vidmantas Alekna, Maria Luisa Bianchi, Patricia Clark, Manuel Díaz Curiel, Hans Peter Dimai, Mikk Jürisson, Anneli Uusküla, Margus Lember, Riina Kallikorm, Olga Lesnyak, Eugene McCloskey, Olga Ershova, Kerrie M. Sanders, Stuart Silverman, Marija Tamulaitiene, Thierry Thomas, Anna N. A. Tosteson, Bengt Jönsson, John A. Kanis

Gepubliceerd in: Quality of Life Research | Uitgave 3/2018

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Abstract

Introduction

The International Costs and Utilities Related to Osteoporotic fractures Study is a multinational observational study set up to describe the costs and quality of life (QoL) consequences of fragility fracture. This paper aims to estimate and compare QoL after hip, vertebral, and distal forearm fracture using time-trade-off (TTO), the EuroQol (EQ) Visual Analogue Scale (EQ-VAS), and the EQ-5D-3L valued using the hypothetical UK value set.

Methods

Data were collected at four time-points for five QoL point estimates: within 2 weeks after fracture (including pre-fracture recall), and at 4, 12, and 18 months after fracture. Health state utility values (HSUVs) were derived for each fracture type and time-point using the three approaches (TTO, EQ-VAS, EQ-5D-3L). HSUV were used to estimate accumulated QoL loss and QoL multipliers.

Results

In total, 1410 patients (505 with hip, 316 with vertebral, and 589 with distal forearm fracture) were eligible for analysis. Across all time-points for the three fracture types, TTO provided the highest HSUVs, whereas EQ-5D-3L consistently provided the lowest HSUVs directly after fracture. Except for 13–18 months after distal forearm fracture, EQ-5D-3L generated lower QoL multipliers than the other two methods, whereas no equally clear pattern was observed between EQ-VAS and TTO. On average, the most marked differences between the three approaches were observed immediately after the fracture.

Conclusions

The approach to derive QoL markedly influences the estimated QoL impact of fracture. Therefore the choice of approach may be important for the outcome and interpretation of cost-effectiveness analysis of fracture prevention.
Bijlagen
Alleen toegankelijk voor geautoriseerde gebruikers
Literatuur
1.
go back to reference Neumann, P. J., Goldie, S. J., & Weinstein, M. C. (2000). Preference-based measures in economic evaluation in health care. Annual Review of Public Health, 21, 587–611.CrossRefPubMed Neumann, P. J., Goldie, S. J., & Weinstein, M. C. (2000). Preference-based measures in economic evaluation in health care. Annual Review of Public Health, 21, 587–611.CrossRefPubMed
2.
go back to reference Neumann, P. J. (2004). Using cost-effectiveness analysis to improve health care: Opportunities and barriers. Oxford: Oxford University Press.CrossRef Neumann, P. J. (2004). Using cost-effectiveness analysis to improve health care: Opportunities and barriers. Oxford: Oxford University Press.CrossRef
3.
go back to reference Drummond, M. F., Sculpher, M. J., Claxton, K., Stoddart, G. L., & Torrance, G. W. (2015). Methods for the economic evaluation of health care programmes. Oxford: Oxford university press. Drummond, M. F., Sculpher, M. J., Claxton, K., Stoddart, G. L., & Torrance, G. W. (2015). Methods for the economic evaluation of health care programmes. Oxford: Oxford university press.
4.
go back to reference Weinstein, M. C., Torrance, G., & McGuire, A. (2009). QALYs: The basics. Value in Health, 12(Suppl 1), S5–S9.CrossRefPubMed Weinstein, M. C., Torrance, G., & McGuire, A. (2009). QALYs: The basics. Value in Health, 12(Suppl 1), S5–S9.CrossRefPubMed
5.
go back to reference Torrance, G. W. (1986). Measurement of health state utilities for economic appraisal. Journal of Health Economics, 5(1), 1–30.CrossRefPubMed Torrance, G. W. (1986). Measurement of health state utilities for economic appraisal. Journal of Health Economics, 5(1), 1–30.CrossRefPubMed
6.
go back to reference Arnold, D., Girling, A., Stevens, A., & Lilford, R. (2009). Comparison of direct and indirect methods of estimating health state utilities for resource allocation: Review and empirical analysis. BMJ, 339, b2688.CrossRefPubMedPubMedCentral Arnold, D., Girling, A., Stevens, A., & Lilford, R. (2009). Comparison of direct and indirect methods of estimating health state utilities for resource allocation: Review and empirical analysis. BMJ, 339, b2688.CrossRefPubMedPubMedCentral
7.
go back to reference Morimoto, T., & Fukui, T. (2002). Utilities measured by rating scale, time trade-off, and standard gamble: Review and reference for health care professionals. Journal of Epidemiology, 12(2), 160–178.CrossRefPubMed Morimoto, T., & Fukui, T. (2002). Utilities measured by rating scale, time trade-off, and standard gamble: Review and reference for health care professionals. Journal of Epidemiology, 12(2), 160–178.CrossRefPubMed
8.
go back to reference Miller, W., Robinson, L. A., & Lawrence, R. S. (2006). Valuing health for regulatory cost-effectiveness analysis. Washington: National Academies Press. Miller, W., Robinson, L. A., & Lawrence, R. S. (2006). Valuing health for regulatory cost-effectiveness analysis. Washington: National Academies Press.
9.
go back to reference Kanis, J. A. (2002). Diagnosis of osteoporosis and assessment of fracture risk. The Lancet, 359(9321), 1929–1936.CrossRef Kanis, J. A. (2002). Diagnosis of osteoporosis and assessment of fracture risk. The Lancet, 359(9321), 1929–1936.CrossRef
10.
go back to reference Cummings, S. R., & Melton, L. J. (2002). Epidemiology and outcomes of osteoporotic fractures. The Lancet, 359(9319), 1761–1767.CrossRef Cummings, S. R., & Melton, L. J. (2002). Epidemiology and outcomes of osteoporotic fractures. The Lancet, 359(9319), 1761–1767.CrossRef
11.
go back to reference Hallberg, I., Rosenqvist, A. M., Kartous, L., Lofman, O., Wahlstrom, O., & Toss, G. (2004). Health-related quality of life after osteoporotic fractures. Osteoporosis International, 15(10), 834–841.CrossRefPubMed Hallberg, I., Rosenqvist, A. M., Kartous, L., Lofman, O., Wahlstrom, O., & Toss, G. (2004). Health-related quality of life after osteoporotic fractures. Osteoporosis International, 15(10), 834–841.CrossRefPubMed
12.
go back to reference Johnell, O., & Kanis, J. A. (2006). An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporosis International, 17(12), 1726–1733.CrossRefPubMed Johnell, O., & Kanis, J. A. (2006). An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporosis International, 17(12), 1726–1733.CrossRefPubMed
13.
go back to reference Hernlund, E., Svedbom, A., Ivergard, M., Compston, J., Cooper, C., Stenmark, J., McCloskey, E. V., Jonsson, B., & Kanis, J. A. (2013). Osteoporosis in the European Union: Medical management, epidemiology and economic burden. A report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA). Archives of Osteoporosis, 8, 136.CrossRefPubMedPubMedCentral Hernlund, E., Svedbom, A., Ivergard, M., Compston, J., Cooper, C., Stenmark, J., McCloskey, E. V., Jonsson, B., & Kanis, J. A. (2013). Osteoporosis in the European Union: Medical management, epidemiology and economic burden. A report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA). Archives of Osteoporosis, 8, 136.CrossRefPubMedPubMedCentral
14.
go back to reference Borgstrom, F., Lekander, I., Ivergard, M., Strom, O., Svedbom, A., Alekna, V., Bianchi, M. L., Clark, P., Curiel, M. D., Dimai, H. P., Jurisson, M., Kallikorm, R., Lesnyak, O., McCloskey, E., Nassonov, E., Sanders, K. M., Silverman, S., Tamulaitiene, M., Thomas, T., Tosteson, A. N., Jonsson, B., & Kanis, J. A. (2013). The international costs and utilities related to osteoporotic fractures study (ICUROS)—Quality of life during the first 4 months after fracture. Osteoporosis International, 24(3), 811–823.CrossRefPubMed Borgstrom, F., Lekander, I., Ivergard, M., Strom, O., Svedbom, A., Alekna, V., Bianchi, M. L., Clark, P., Curiel, M. D., Dimai, H. P., Jurisson, M., Kallikorm, R., Lesnyak, O., McCloskey, E., Nassonov, E., Sanders, K. M., Silverman, S., Tamulaitiene, M., Thomas, T., Tosteson, A. N., Jonsson, B., & Kanis, J. A. (2013). The international costs and utilities related to osteoporotic fractures study (ICUROS)—Quality of life during the first 4 months after fracture. Osteoporosis International, 24(3), 811–823.CrossRefPubMed
15.
go back to reference Torrance, G. W., Thomas, W. H., & Sackett, D. L. (1972). A utility maximization model for evaluation of health care programs. Health Services Research, 7(2), 118.PubMedPubMedCentral Torrance, G. W., Thomas, W. H., & Sackett, D. L. (1972). A utility maximization model for evaluation of health care programs. Health Services Research, 7(2), 118.PubMedPubMedCentral
16.
go back to reference Oppe, M., Devlin, N. J., & Szende, A. (2007). EQ-5D value sets: Inventory, comparative review and user guide. Cham: Springer. Oppe, M., Devlin, N. J., & Szende, A. (2007). EQ-5D value sets: Inventory, comparative review and user guide. Cham: Springer.
17.
go back to reference Dolan, P. (1997). Modeling valuations for EuroQol health states. Medical Care, 35(11), 1095–1108.CrossRefPubMed Dolan, P. (1997). Modeling valuations for EuroQol health states. Medical Care, 35(11), 1095–1108.CrossRefPubMed
18.
go back to reference Barber, J. A., & Thompson, S. G. (2000). Analysis of cost data in randomized trials: An application of the non-parametric bootstrap. Statistics in Medicine, 19(23), 3219–3236.CrossRefPubMed Barber, J. A., & Thompson, S. G. (2000). Analysis of cost data in randomized trials: An application of the non-parametric bootstrap. Statistics in Medicine, 19(23), 3219–3236.CrossRefPubMed
19.
go back to reference Peeters, Y., & Stiggelbout, A. M. (2010). Health state valuations of patients and the general public analytically compared: A meta-analytical comparison of patient and population health state utilities. Value in Health, 13(2), 306–309.CrossRefPubMed Peeters, Y., & Stiggelbout, A. M. (2010). Health state valuations of patients and the general public analytically compared: A meta-analytical comparison of patient and population health state utilities. Value in Health, 13(2), 306–309.CrossRefPubMed
20.
go back to reference Bremner, K. E., Chong, C. A., Tomlinson, G., Alibhai, S. M., & Krahn, M. D. (2007). A review and meta-analysis of prostate cancer utilities. Medical Decision Making, 27(3), 288–298.CrossRefPubMed Bremner, K. E., Chong, C. A., Tomlinson, G., Alibhai, S. M., & Krahn, M. D. (2007). A review and meta-analysis of prostate cancer utilities. Medical Decision Making, 27(3), 288–298.CrossRefPubMed
21.
go back to reference De Wit, G. A., Busschbach, J. J., & De Charro, F. T. (2000). Sensitivity and perspective in the valuation of health status: Whose values count? Health Economics, 9(2), 109–126.CrossRefPubMed De Wit, G. A., Busschbach, J. J., & De Charro, F. T. (2000). Sensitivity and perspective in the valuation of health status: Whose values count? Health Economics, 9(2), 109–126.CrossRefPubMed
22.
go back to reference Noel, C. W., Lee, D. J., Kong, Q., Xu, W., Simpson, C., Brown, D., Gilbert, R. W., Gullane, P. J., Irish, J. C., Huang, S. H., O’Sullivan, B., Goldstein, D. P., & de Almeida, J. R. (2015). Comparison of health state utility measures in patients with head and neck cancer. JAMA Otolaryngol Head Neck Surgery, 141(8), 696–703.CrossRef Noel, C. W., Lee, D. J., Kong, Q., Xu, W., Simpson, C., Brown, D., Gilbert, R. W., Gullane, P. J., Irish, J. C., Huang, S. H., O’Sullivan, B., Goldstein, D. P., & de Almeida, J. R. (2015). Comparison of health state utility measures in patients with head and neck cancer. JAMA Otolaryngol Head Neck Surgery, 141(8), 696–703.CrossRef
23.
go back to reference Zethraeus, N., & Johannesson, M. (1999). A comparison of patient and social tariff values derived from the time trade-off method. Health Economics, 8(6), 541–545.CrossRefPubMed Zethraeus, N., & Johannesson, M. (1999). A comparison of patient and social tariff values derived from the time trade-off method. Health Economics, 8(6), 541–545.CrossRefPubMed
24.
go back to reference Gabriel, S. E., Kneeland, T. S., Melton, L. J., 3rd, Moncur, M. M., Ettinger, B., & Tosteson, A. N. (1999). Health-related quality of life in economic evaluations for osteoporosis: Whose values should we use? Medical Decision Making, 19(2), 141–148.CrossRefPubMed Gabriel, S. E., Kneeland, T. S., Melton, L. J., 3rd, Moncur, M. M., Ettinger, B., & Tosteson, A. N. (1999). Health-related quality of life in economic evaluations for osteoporosis: Whose values should we use? Medical Decision Making, 19(2), 141–148.CrossRefPubMed
25.
go back to reference Brazier, J., Akehurst, R., Brennan, A., Dolan, P., Claxton, K., McCabe, C., Sculpher, M., & Tsuchyia, A. (2005). Should patients have a greater role in valuing health states? Applied Health Economics and Health Policy, 4(4), 201–208.CrossRefPubMed Brazier, J., Akehurst, R., Brennan, A., Dolan, P., Claxton, K., McCabe, C., Sculpher, M., & Tsuchyia, A. (2005). Should patients have a greater role in valuing health states? Applied Health Economics and Health Policy, 4(4), 201–208.CrossRefPubMed
26.
go back to reference Burstrom, K., Johannesson, M., & Diderichsen, F. (2006). A comparison of individual and social time trade-off values for health states in the general population. Health Policy, 76(3), 359–370.CrossRefPubMed Burstrom, K., Johannesson, M., & Diderichsen, F. (2006). A comparison of individual and social time trade-off values for health states in the general population. Health Policy, 76(3), 359–370.CrossRefPubMed
27.
go back to reference Versteegh, M. M., & Brouwer, W. B. (2016). Patient and general public preferences for health states: A call to reconsider current guidelines. Social Science & Medicine, 165, 66–74.CrossRef Versteegh, M. M., & Brouwer, W. B. (2016). Patient and general public preferences for health states: A call to reconsider current guidelines. Social Science & Medicine, 165, 66–74.CrossRef
28.
go back to reference Neumann, P. J., Sanders, G. D., Russell, L. B., Siegel, J. E., & Ganiats, T. G. (2016). Cost-effectiveness in health and medicine. Oxford: Oxford University Press.CrossRef Neumann, P. J., Sanders, G. D., Russell, L. B., Siegel, J. E., & Ganiats, T. G. (2016). Cost-effectiveness in health and medicine. Oxford: Oxford University Press.CrossRef
29.
go back to reference Excellence, N. I., f., C., & Excellence, N. I. f. C. (2004). Guide to the methods of technology appraisal (p. 12). London: NICE. Excellence, N. I., f., C., & Excellence, N. I. f. C. (2004). Guide to the methods of technology appraisal (p. 12). London: NICE.
30.
go back to reference Nederland, Z. (2015). Richtlijn voor het uitvoeren van economische evaluaties in de gezondheidszorg. Diemen: Zorginstituut Nederland. Nederland, Z. (2015). Richtlijn voor het uitvoeren van economische evaluaties in de gezondheidszorg. Diemen: Zorginstituut Nederland.
31.
go back to reference Weinstein, M. C., Siegel, J. E., Gold, M. R., Kamlet, M. S., & Russell, L. B. (1996). Recommendations of the panel on cost-effectiveness in health and medicine. JAMA, 276(15), 1253–1258.CrossRefPubMed Weinstein, M. C., Siegel, J. E., Gold, M. R., Kamlet, M. S., & Russell, L. B. (1996). Recommendations of the panel on cost-effectiveness in health and medicine. JAMA, 276(15), 1253–1258.CrossRefPubMed
32.
go back to reference Sanders, G. D., Neumann, P. J., Basu, A., Brock, D. W., Feeny, D., Krahn, M., Kuntz, K. M., Meltzer, D. O., Owens, D. K., Prosser, L. A., Salomon, J. A., Sculpher, M. J., Trikalinos, T. A., Russell, L. B., Siegel, J. E., & Ganiats, T. G. (2016). Recommendations for conduct, methodological practices, and reporting of cost-effectiveness analyses: second panel on cost-effectiveness in health and medicine. JAMA, 316(10), 1093–1103.CrossRefPubMed Sanders, G. D., Neumann, P. J., Basu, A., Brock, D. W., Feeny, D., Krahn, M., Kuntz, K. M., Meltzer, D. O., Owens, D. K., Prosser, L. A., Salomon, J. A., Sculpher, M. J., Trikalinos, T. A., Russell, L. B., Siegel, J. E., & Ganiats, T. G. (2016). Recommendations for conduct, methodological practices, and reporting of cost-effectiveness analyses: second panel on cost-effectiveness in health and medicine. JAMA, 316(10), 1093–1103.CrossRefPubMed
33.
go back to reference Board, P. B. (2003). General Guidelines for economic evaluations from the Pharmaceutical Benefits Board (LFNAR 2003: 2). Solna: Swedish Pharmaceutical Benefits Board. Board, P. B. (2003). General Guidelines for economic evaluations from the Pharmaceutical Benefits Board (LFNAR 2003: 2). Solna: Swedish Pharmaceutical Benefits Board.
34.
go back to reference Xie, F., Gaebel, K., Perampaladas, K., Doble, B., & Pullenayegum, E. (2014). Comparing EQ-5D valuation studies: A systematic review and methodological reporting checklist. Medical Decision Making, 34(1), 8–20.CrossRefPubMed Xie, F., Gaebel, K., Perampaladas, K., Doble, B., & Pullenayegum, E. (2014). Comparing EQ-5D valuation studies: A systematic review and methodological reporting checklist. Medical Decision Making, 34(1), 8–20.CrossRefPubMed
35.
go back to reference Oppong, R., Kaambwa, B., Nuttall, J., Hood, K., Smith, R. D., & Coast, J. (2013). The impact of using different tariffs to value EQ-5D health state descriptions: An example from a study of acute cough/lower respiratory tract infections in seven countries. The European Journal of Health Economics, 14(2), 197–209.CrossRefPubMed Oppong, R., Kaambwa, B., Nuttall, J., Hood, K., Smith, R. D., & Coast, J. (2013). The impact of using different tariffs to value EQ-5D health state descriptions: An example from a study of acute cough/lower respiratory tract infections in seven countries. The European Journal of Health Economics, 14(2), 197–209.CrossRefPubMed
36.
go back to reference Persson, U. (2014). Hypothetical versus experience-based EQ-5D valuations: What are the implications for health economic evaluations?. Amsterdam: ISPOR. Persson, U. (2014). Hypothetical versus experience-based EQ-5D valuations: What are the implications for health economic evaluations?. Amsterdam: ISPOR.
37.
go back to reference Ekman, M., Berg, J., Wimo, A., Jönsson, L., & McBurney, C. (2007). Health utilities in mild cognitive impairment and dementia: A population study in Sweden. International Journal of Geriatric Psychiatry, 22(7), 649–655.CrossRefPubMed Ekman, M., Berg, J., Wimo, A., Jönsson, L., & McBurney, C. (2007). Health utilities in mild cognitive impairment and dementia: A population study in Sweden. International Journal of Geriatric Psychiatry, 22(7), 649–655.CrossRefPubMed
38.
go back to reference Lesnyak, O., Ershova, O., Belova, K., Gladkova, E., Sinitsina, O., Ganert, O., Romanova, M., Khodirev, V., Johansson, H., McCloskey, E., & Kanis, J. A. (2012). Epidemiology of fracture in the Russian Federation and the development of a FRAX model. Archives of Osteoporosis, 7, 67–73.CrossRefPubMed Lesnyak, O., Ershova, O., Belova, K., Gladkova, E., Sinitsina, O., Ganert, O., Romanova, M., Khodirev, V., Johansson, H., McCloskey, E., & Kanis, J. A. (2012). Epidemiology of fracture in the Russian Federation and the development of a FRAX model. Archives of Osteoporosis, 7, 67–73.CrossRefPubMed
39.
go back to reference Marsh, J., Bryant, D., & MacDonald, S. J. (2009). Older patients can accurately recall their preoperative health status six weeks following total hip arthroplasty. The Journal of Bone & Joint Surgery, 91(12), 2827–2837.CrossRef Marsh, J., Bryant, D., & MacDonald, S. J. (2009). Older patients can accurately recall their preoperative health status six weeks following total hip arthroplasty. The Journal of Bone & Joint Surgery, 91(12), 2827–2837.CrossRef
40.
go back to reference Rohde, G., Haugeberg, G., Mengshoel, A. M., Moum, T., & Wahl, A. K. (2009). No long-term impact of low-energy distal radius fracture on health-related quality of life and global quality of life: A case-control study. BMC Musculoskeletal Disorders, 10, 106.CrossRefPubMedPubMedCentral Rohde, G., Haugeberg, G., Mengshoel, A. M., Moum, T., & Wahl, A. K. (2009). No long-term impact of low-energy distal radius fracture on health-related quality of life and global quality of life: A case-control study. BMC Musculoskeletal Disorders, 10, 106.CrossRefPubMedPubMedCentral
41.
go back to reference Borgstrom, F., Zethraeus, N., Johnell, O., Lidgren, L., Ponzer, S., Svensson, O., Abdon, P., Ornstein, E., Lunsjo, K., Thorngren, K. G., Sernbo, I., Rehnberg, C., & Jonsson, B. (2006). Costs and quality of life associated with osteoporosis-related fractures in Sweden. Osteoporosis International, 17(5), 637–650.CrossRefPubMed Borgstrom, F., Zethraeus, N., Johnell, O., Lidgren, L., Ponzer, S., Svensson, O., Abdon, P., Ornstein, E., Lunsjo, K., Thorngren, K. G., Sernbo, I., Rehnberg, C., & Jonsson, B. (2006). Costs and quality of life associated with osteoporosis-related fractures in Sweden. Osteoporosis International, 17(5), 637–650.CrossRefPubMed
Metagegevens
Titel
Quality of life after hip, vertebral, and distal forearm fragility fractures measured using the EQ-5D-3L, EQ-VAS, and time-trade-off: results from the ICUROS
Auteurs
Axel Svedbom
Fredrik Borgström
Emma Hernlund
Oskar Ström
Vidmantas Alekna
Maria Luisa Bianchi
Patricia Clark
Manuel Díaz Curiel
Hans Peter Dimai
Mikk Jürisson
Anneli Uusküla
Margus Lember
Riina Kallikorm
Olga Lesnyak
Eugene McCloskey
Olga Ershova
Kerrie M. Sanders
Stuart Silverman
Marija Tamulaitiene
Thierry Thomas
Anna N. A. Tosteson
Bengt Jönsson
John A. Kanis
Publicatiedatum
12-12-2017
Uitgeverij
Springer International Publishing
Gepubliceerd in
Quality of Life Research / Uitgave 3/2018
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-017-1748-5